. 2017 Jan 17;5:4. doi: 10.1186/s40425-016-0204-3

Table 3.

Abscopal effect

	^aResponders/Cured		^bImmune to Rechallenge	^cIFN-γ Mean Spots ± SD
	# Mice/Total	Percent	^bImmune to Rechallenge	^cIFN-γ Mean Spots ± SD
Control	0/7	0%	0/7	N/A
Radiation	0/8	0%	0/8	N/A
Vaccine + Rad (Schedule 2)	4/8	50%	4/4	147.2 ± 7.8

To test for abscopal effect, established Renca-MUC1tumors were treated either with vehicle (control), 8Gy radiation or vaccine followed by radiation (schedule 2, Fig. 2a). ^aResponders/Cured: Responders were characterized by inhibition of tumor growth or complete tumor regression. ^bAt an early time point after treatment, 7 days after radiation and one day after the second vaccine treatment, mice were rechallenged with Renca-MUC1 cells on the contralateral left flank. ^cOn day 70, the splenocytes of mice immune to rechallenge were tested in IFN-γ ELISPOT assay